Table 1.
Factors that contribute to immunosuppression in the TME of CRC.
Classes | Immunosuppressors | Major Immune Cells Affected | References |
---|---|---|---|
Cell surface protein | PD-1 | T cell, NK cell, TAM, DC | [45,46,47,48,49] |
TIGIT | T cell, NK cell | [50,51] | |
TGFβ RII | Treg | [52,53,54,55] | |
GARP | CD4+ and CD8+ T cells | [56] | |
CD39 | NK cell | [57] | |
CD73 | Effector T cell | [58] | |
A2A adenosine receptors | T cell | [57] | |
CCR8 | Treg | [59,60] | |
Disrupted Immunosurveillance
Contributors |
Major Immune Cells Affected | References | |
NKG2D receptor | NK cell | [61,62] | |
TLRs | Innate immune cell | [63] | |
CD80 | T cell | [64] | |
Cytokines/Chemokines | Immunosuppressors | Major Immune Cells Affected | References |
TGFβ | Treg | [65] | |
VEGF | T cell, MDSC, DC | [66,67] | |
IL-6 | CD4+ and CD8+ T cells | [68,69] | |
CXCL3 and CXCL4 | Treg, CD8+ T cell | [70,71] | |
HMGB1 | PMDDC | [72] | |
Disrupted Immune Activators | Major Immune Cells Affected | References | |
IL-12 | NK cell, T cell | [73] | |
IL-15 | NK cell, CD8+ T cell | [74] | |
IL-24 | CD4+ and CD8+ T cells | [75,76,77] | |
CXCL9, CXCL10, and CXCL11 | CD4+ and CD8+ T cells | [78,79,80] | |
Phosphatase | Immunosuppressor | Major Immune Cells Affected | References |
SHP2 | CD4+ and CD8+ T cells | [81,82,83] | |
Transcriptional factors | Immunosuppressors | Major Immune Cells Affected | References |
PRC2 | Th1 and CD8+ T cells | [84] | |
FOXM1 | BMDC | [85] | |
NF-κB | DC | [86] | |
STAT1 | CD4+ T cell | [83] | |
STAT3 | CD4+ T cell, DC | [82,87] | |
TRF2 | NK cell | [88] | |
Metabolic enzymes | Immunosuppressors | Major Immune Cells Affected | References |
ODC | M1 macrophage | [20,89] | |
IDO1 | CD4+ and CD8+ T cells, NK cell, MDSC | [90,91] | |
Other factors | Immunosuppressive factors | Major Immune Cells Affected | References |
Extracellular adenosine level | T cell | [57,58] | |
Hypoxia | Treg, CD4+ effector T cell, MDSC, TAM, DC | [92,93] |
Abbreviations: dendritic cell, DC; tyrosine-based inhibitory motif domain, TIGIT; high mobility group box-1, HMGB1; peritoneal macrophage-derived dendritic cells, PMDDC; ornithine decarboxylase, ODC.